Federated Hermes’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.1M Sell
53,199
-1,879
-3% -$1.02M 0.04% 408
2025
Q4
$31.9M Sell
55,078
-8,611
-14% -$4.87M 0.05% 343
2025
Q3
$30.9M Buy
63,689
+643
+1% +$299K 0.05% 351
2025
Q2
$25.6M Sell
63,046
-12,315
-16% -$5.15M 0.05% 376
2025
Q1
$37.5M Sell
75,361
-13,696
-15% -$7.42M 0.08% 283
2024
Q4
$46.3M Sell
89,057
-1,534
-2% -$843K 0.1% 246
2024
Q3
$56M Buy
90,591
+2,839
+3% +$1.68M 0.12% 221
2024
Q2
$48.5M Sell
87,752
-3,723
-4% -$2.13M 0.12% 227
2024
Q1
$53.2M Sell
91,475
-2,127
-2% -$1.19M 0.12% 214
2023
Q4
$49.7M Sell
93,602
-55,122
-37% -$26.7M 0.12% 212
2023
Q3
$75.3M Sell
148,724
-2,801
-2% -$1.49M 0.2% 126
2023
Q2
$79.1M Buy
151,525
+5,855
+4% +$3.16M 0.2% 116
2023
Q1
$84M Sell
145,670
-1,201
-0.8% -$677K 0.21% 100
2022
Q4
$80.9M Sell
146,871
-41,387
-22% -$21.9M 0.22% 95
2022
Q3
$95.5M Sell
188,258
-76,160
-29% -$42.6M 0.28% 75
2022
Q2
$144M Sell
264,418
-18,757
-7% -$10.3M 0.39% 50
2022
Q1
$167M Sell
283,175
-34,456
-11% -$19.8M 0.38% 56
2021
Q4
$212M Sell
317,631
-3,283
-1% -$2.05M 0.39% 54
2021
Q3
$183M Buy
320,914
+26,563
+9% +$14.6M 0.35% 64
2021
Q2
$148M Buy
294,351
+11,064
+4% +$5.22M 0.28% 88
2021
Q1
$129M Buy
283,287
+17,227
+6% +$8.22M 0.25% 103
2020
Q4
$124M Buy
266,060
+3,277
+1% +$1.54M 0.25% 97
2020
Q3
$116M Sell
262,783
-557
-0.2% -$230K 0.27% 89
2020
Q2
$95.4M Sell
263,340
-18,440
-7% -$6.18M 0.24% 102
2020
Q1
$79.9M Sell
281,780
-56,560
-17% -$17.8M 0.23% 97
2019
Q4
$110M Buy
338,340
+20,211
+6% +$6.13M 0.25% 87
2019
Q3
$92.7M Sell
318,129
-139,098
-30% -$39.8M 0.23% 98
2019
Q2
$134M Sell
457,227
-3,549
-0.8% -$977K 0.33% 62
2019
Q1
$126M Sell
460,776
-49,023
-10% -$12.2M 0.31% 66
2018
Q4
$114M Sell
509,799
-51,150
-9% -$12M 0.31% 66
2018
Q3
$137M Buy
560,949
+554,045
+8,025% +$127M 0.32% 67
2018
Q2
$1.43M Sell
6,904
-172
-2% -$36.5K ﹤0.01% 1156
2018
Q1
$1.46M Sell
7,076
-37,838
-84% -$7.94M ﹤0.01% 1086
2017
Q4
$8.53M Buy
44,914
+36,379
+426% +$6.97M 0.02% 466
2017
Q3
$1.61M Sell
8,535
-42,553
-83% -$7.71M ﹤0.01% 1016
2017
Q2
$8.91M Buy
51,088
+43,000
+532% +$7.22M 0.03% 425
2017
Q1
$1.24M Sell
8,088
-1,343
-14% -$205K ﹤0.01% 1102
2016
Q4
$1.33M Buy
9,431
+1,210
+15% +$178K ﹤0.01% 1037
2016
Q3
$1.31M Sell
8,221
-231
-3% -$35.6K ﹤0.01% 1018
2016
Q2
$1.25M Sell
8,452
-252
-3% -$37.2K ﹤0.01% 1029
2016
Q1
$1.23M Sell
8,704
-2,673
-23% -$358K ﹤0.01% 1025
2015
Q4
$1.61M Buy
11,377
+1,120
+11% +$149K 0.01% 960
2015
Q3
$1.25M Sell
10,257
-2,491
-20% -$325K ﹤0.01% 1030
2015
Q2
$1.65M Hold
12,748
0.01% 993
2015
Q1
$1.71M Buy
12,748
+2,023
+19% +$261K 0.01% 1018
2014
Q4
$1.34M Sell
10,725
-2,031
-16% -$247K ﹤0.01% 1088
2014
Q3
$1.55M Sell
12,756
-723,520
-98% -$88M 0.01% 1059
2014
Q2
$86.9M Sell
736,276
-554
-0.1% -$65.2K 0.27% 71
2014
Q1
$88.6M Buy
736,830
+317
+0% +$37.7K 0.3% 67
2013
Q4
$82M Sell
736,513
-13,980
-2% -$1.39M 0.28% 76
2013
Q3
$69.2M Buy
750,493
+311,369
+71% +$28.2M 0.27% 77
2013
Q2
$37.2M Buy
+439,124
New +$36.6M 0.15% 135

Other funds holding TMO

Federated Hermes's TMO Position: Q1 2026 in Review

Federated Hermes reduced its Thermo Fisher Scientific (TMO) stake by 3.4% in Q1 2026, selling an estimated $1.02M and leaving 53,199 shares worth $26.1M. The position accounts for 0.04% of the portfolio, ranked #408.

Federated Hermes first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $212M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Federated Hermes held 53,199 shares of Thermo Fisher Scientific worth $26.1M as of Q1 2026.
  • Federated Hermes sold 1,879 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.02M.
  • Thermo Fisher Scientific made up 0.04% of Federated Hermes's portfolio in Q1 2026, its #408 holding.
  • Federated Hermes first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Federated Hermes's Thermo Fisher Scientific position peaked at $212M in Q4 2021.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.